Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oropharyngeal Neoplasms | 28 | 2022 | 440 | 8.390 |
Why?
|
Head and Neck Neoplasms | 51 | 2022 | 2591 | 5.410 |
Why?
|
Reconstructive Surgical Procedures | 28 | 2021 | 2137 | 4.660 |
Why?
|
Free Tissue Flaps | 13 | 2022 | 284 | 3.610 |
Why?
|
Carcinoma, Squamous Cell | 33 | 2022 | 3876 | 3.310 |
Why?
|
Thyroidectomy | 12 | 2020 | 892 | 3.110 |
Why?
|
Laryngectomy | 11 | 2020 | 234 | 3.080 |
Why?
|
Robotics | 14 | 2017 | 859 | 2.900 |
Why?
|
Neck | 14 | 2021 | 698 | 2.830 |
Why?
|
Surgical Flaps | 15 | 2021 | 1630 | 2.780 |
Why?
|
Natural Orifice Endoscopic Surgery | 8 | 2021 | 126 | 2.580 |
Why?
|
Papillomavirus Infections | 17 | 2022 | 1470 | 2.500 |
Why?
|
Neck Dissection | 9 | 2020 | 215 | 2.280 |
Why?
|
Pharyngeal Diseases | 4 | 2019 | 139 | 2.010 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 7 | 2021 | 329 | 1.930 |
Why?
|
Parotid Neoplasms | 4 | 2021 | 161 | 1.880 |
Why?
|
Otolaryngology | 6 | 2018 | 652 | 1.840 |
Why?
|
Papillomaviridae | 12 | 2022 | 1124 | 1.710 |
Why?
|
Microsurgery | 5 | 2018 | 815 | 1.650 |
Why?
|
Pharyngectomy | 4 | 2016 | 45 | 1.550 |
Why?
|
Mouth | 10 | 2021 | 415 | 1.550 |
Why?
|
Tongue Neoplasms | 5 | 2015 | 172 | 1.500 |
Why?
|
Deglutition Disorders | 5 | 2021 | 566 | 1.400 |
Why?
|
Endoscopy | 7 | 2021 | 1754 | 1.390 |
Why?
|
Head | 6 | 2021 | 845 | 1.320 |
Why?
|
Laryngeal Neoplasms | 6 | 2017 | 490 | 1.210 |
Why?
|
Surgery, Oral | 3 | 2014 | 149 | 1.200 |
Why?
|
Alphapapillomavirus | 6 | 2022 | 220 | 1.180 |
Why?
|
Postoperative Complications | 26 | 2021 | 15053 | 1.130 |
Why?
|
Oral Surgical Procedures | 4 | 2021 | 162 | 1.010 |
Why?
|
Cutaneous Fistula | 2 | 2013 | 84 | 0.930 |
Why?
|
Paranasal Sinus Neoplasms | 3 | 2021 | 235 | 0.910 |
Why?
|
Pharynx | 2 | 2014 | 419 | 0.840 |
Why?
|
Parathyroidectomy | 2 | 2020 | 243 | 0.840 |
Why?
|
Rhytidoplasty | 1 | 2021 | 57 | 0.820 |
Why?
|
Nasal Septum | 3 | 2006 | 134 | 0.800 |
Why?
|
Airway Obstruction | 2 | 2018 | 651 | 0.790 |
Why?
|
Nose Neoplasms | 2 | 2021 | 244 | 0.760 |
Why?
|
Sialometaplasia, Necrotizing | 1 | 2019 | 6 | 0.760 |
Why?
|
Education | 2 | 2013 | 540 | 0.740 |
Why?
|
Larynx, Artificial | 3 | 2017 | 68 | 0.730 |
Why?
|
Computer-Assisted Instruction | 2 | 2013 | 379 | 0.720 |
Why?
|
Parathyroid Glands | 2 | 2018 | 519 | 0.720 |
Why?
|
Speech Disorders | 2 | 2021 | 181 | 0.710 |
Why?
|
Anastomosis, Surgical | 3 | 2017 | 958 | 0.710 |
Why?
|
Leeching | 1 | 2018 | 6 | 0.700 |
Why?
|
Nose Deformities, Acquired | 1 | 2018 | 40 | 0.690 |
Why?
|
Vascular Surgical Procedures | 3 | 2018 | 1510 | 0.670 |
Why?
|
Patient Care Planning | 2 | 2021 | 933 | 0.670 |
Why?
|
Surgery, Computer-Assisted | 3 | 2014 | 1018 | 0.650 |
Why?
|
Deglutition | 2 | 2021 | 200 | 0.640 |
Why?
|
Scapula | 1 | 2018 | 154 | 0.630 |
Why?
|
Thyroid Diseases | 2 | 2017 | 387 | 0.620 |
Why?
|
Glossectomy | 2 | 2016 | 51 | 0.610 |
Why?
|
Hyperemia | 1 | 2018 | 226 | 0.610 |
Why?
|
Pharyngeal Neoplasms | 2 | 2014 | 90 | 0.610 |
Why?
|
Humans | 143 | 2022 | 708843 | 0.610 |
Why?
|
Fibrin Tissue Adhesive | 2 | 2007 | 79 | 0.600 |
Why?
|
Arteries | 3 | 2020 | 1131 | 0.590 |
Why?
|
Postoperative Care | 3 | 2017 | 1514 | 0.570 |
Why?
|
Tongue | 6 | 2016 | 402 | 0.550 |
Why?
|
Antithrombins | 1 | 2018 | 294 | 0.550 |
Why?
|
Mouth Neoplasms | 5 | 2021 | 564 | 0.550 |
Why?
|
Skin Transplantation | 2 | 2018 | 1130 | 0.530 |
Why?
|
Pain, Postoperative | 2 | 2020 | 1599 | 0.530 |
Why?
|
Salvage Therapy | 7 | 2018 | 1296 | 0.520 |
Why?
|
Jugular Veins | 1 | 2015 | 218 | 0.520 |
Why?
|
Hypopharynx | 2 | 2019 | 54 | 0.520 |
Why?
|
Palatine Tonsil | 1 | 2014 | 193 | 0.500 |
Why?
|
Endoscopes | 1 | 2014 | 174 | 0.500 |
Why?
|
Retrospective Studies | 41 | 2022 | 71483 | 0.490 |
Why?
|
Tracheostomy | 3 | 2017 | 400 | 0.480 |
Why?
|
Laser Therapy | 2 | 2012 | 1059 | 0.470 |
Why?
|
Middle Aged | 66 | 2022 | 213752 | 0.450 |
Why?
|
Cadaver | 6 | 2019 | 1366 | 0.450 |
Why?
|
Graft Survival | 5 | 2018 | 3767 | 0.440 |
Why?
|
Tonsillectomy | 3 | 2016 | 274 | 0.440 |
Why?
|
Nasopharynx | 1 | 2014 | 387 | 0.440 |
Why?
|
Tumor Virus Infections | 1 | 2014 | 453 | 0.440 |
Why?
|
Skull Base | 1 | 2014 | 285 | 0.430 |
Why?
|
Tonsillar Neoplasms | 1 | 2011 | 52 | 0.430 |
Why?
|
Human papillomavirus 16 | 4 | 2017 | 262 | 0.420 |
Why?
|
Carcinoma | 4 | 2016 | 2307 | 0.410 |
Why?
|
Salivary Glands | 1 | 2012 | 232 | 0.410 |
Why?
|
Male | 81 | 2022 | 349524 | 0.400 |
Why?
|
Internship and Residency | 4 | 2018 | 5556 | 0.400 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2010 | 76 | 0.400 |
Why?
|
Feasibility Studies | 6 | 2020 | 4883 | 0.390 |
Why?
|
Parotid Gland | 2 | 2021 | 164 | 0.390 |
Why?
|
Intubation, Intratracheal | 1 | 2018 | 1312 | 0.390 |
Why?
|
Aged | 47 | 2022 | 161488 | 0.380 |
Why?
|
Tracheal Stenosis | 1 | 2012 | 223 | 0.380 |
Why?
|
Temporal Bone | 1 | 2014 | 669 | 0.380 |
Why?
|
Thyroid Neoplasms | 3 | 2017 | 2219 | 0.370 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1758 | 0.370 |
Why?
|
Equipment Failure | 1 | 2012 | 586 | 0.370 |
Why?
|
Laryngoscopy | 3 | 2011 | 712 | 0.370 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2021 | 8877 | 0.360 |
Why?
|
Female | 74 | 2021 | 375205 | 0.360 |
Why?
|
Epistaxis | 2 | 2007 | 109 | 0.360 |
Why?
|
Tongue Diseases | 1 | 2009 | 71 | 0.350 |
Why?
|
Length of Stay | 10 | 2021 | 6257 | 0.350 |
Why?
|
Rhabdomyosarcoma | 1 | 2011 | 381 | 0.350 |
Why?
|
Education, Medical, Undergraduate | 1 | 2017 | 988 | 0.340 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2009 | 84 | 0.340 |
Why?
|
Combined Modality Therapy | 9 | 2021 | 8896 | 0.340 |
Why?
|
Clinical Competence | 5 | 2018 | 4615 | 0.340 |
Why?
|
Device Removal | 2 | 2017 | 656 | 0.330 |
Why?
|
Enteral Nutrition | 2 | 2016 | 725 | 0.330 |
Why?
|
Hospital Costs | 1 | 2014 | 982 | 0.330 |
Why?
|
Epiglottis | 2 | 2017 | 84 | 0.320 |
Why?
|
DNA, Viral | 7 | 2022 | 2287 | 0.310 |
Why?
|
Dysphonia | 1 | 2009 | 128 | 0.310 |
Why?
|
Neoplasm Staging | 15 | 2021 | 11126 | 0.310 |
Why?
|
Cone-Beam Computed Tomography | 3 | 2015 | 403 | 0.300 |
Why?
|
Surgical Wound Infection | 4 | 2022 | 1490 | 0.300 |
Why?
|
Fibula | 2 | 2021 | 258 | 0.290 |
Why?
|
Adult | 42 | 2021 | 211041 | 0.280 |
Why?
|
Curriculum | 2 | 2016 | 3329 | 0.280 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2007 | 124 | 0.280 |
Why?
|
Laparoscopy | 1 | 2017 | 1981 | 0.280 |
Why?
|
Peptide Fragments | 1 | 2018 | 5141 | 0.270 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3308 | 0.270 |
Why?
|
Hemostatics | 1 | 2007 | 224 | 0.260 |
Why?
|
Nasopharyngeal Neoplasms | 2 | 2017 | 268 | 0.260 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2016 | 782 | 0.260 |
Why?
|
Lymphatic Metastasis | 3 | 2022 | 2951 | 0.250 |
Why?
|
Facial Nerve Diseases | 1 | 2004 | 52 | 0.250 |
Why?
|
Prospective Studies | 16 | 2021 | 50597 | 0.250 |
Why?
|
Aged, 80 and over | 19 | 2022 | 58184 | 0.240 |
Why?
|
Thyroid Gland | 4 | 2018 | 1173 | 0.240 |
Why?
|
Treatment Outcome | 18 | 2021 | 61932 | 0.240 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2004 | 141 | 0.240 |
Why?
|
Patient Discharge | 2 | 2021 | 2980 | 0.240 |
Why?
|
Growth Substances | 1 | 2005 | 812 | 0.240 |
Why?
|
Risk Assessment | 10 | 2021 | 23284 | 0.230 |
Why?
|
Mandible | 4 | 2016 | 713 | 0.230 |
Why?
|
Nasal Cavity | 2 | 2021 | 307 | 0.220 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2014 | 1694 | 0.220 |
Why?
|
Joint Instability | 1 | 2009 | 748 | 0.220 |
Why?
|
Cartilage | 1 | 2005 | 806 | 0.220 |
Why?
|
Fistula | 2 | 2013 | 216 | 0.210 |
Why?
|
Cause of Death | 1 | 2011 | 3497 | 0.200 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2779 | 0.200 |
Why?
|
Blood-Brain Barrier | 2 | 1998 | 992 | 0.200 |
Why?
|
Prognosis | 16 | 2021 | 28919 | 0.200 |
Why?
|
Heme Oxygenase (Decyclizing) | 2 | 1998 | 168 | 0.200 |
Why?
|
Hospital Mortality | 1 | 2014 | 5095 | 0.200 |
Why?
|
Chondrocytes | 1 | 2005 | 769 | 0.200 |
Why?
|
Cervical Plexus | 1 | 2019 | 12 | 0.190 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2020 | 1829 | 0.190 |
Why?
|
Orthognathic Surgical Procedures | 1 | 2021 | 107 | 0.190 |
Why?
|
Antibiotic Prophylaxis | 3 | 2022 | 623 | 0.190 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2004 | 622 | 0.190 |
Why?
|
Cartilage, Articular | 1 | 2006 | 1041 | 0.190 |
Why?
|
Dissection | 2 | 2019 | 281 | 0.180 |
Why?
|
Gastrostomy | 3 | 2017 | 299 | 0.180 |
Why?
|
Disease-Free Survival | 6 | 2017 | 7026 | 0.180 |
Why?
|
Societies, Medical | 3 | 2021 | 3776 | 0.180 |
Why?
|
Anti-Infective Agents, Local | 1 | 2021 | 234 | 0.180 |
Why?
|
Databases as Topic | 1 | 2021 | 480 | 0.180 |
Why?
|
Maryland | 2 | 2016 | 276 | 0.180 |
Why?
|
Neurilemmoma | 1 | 2004 | 524 | 0.180 |
Why?
|
Maxilla | 1 | 2021 | 454 | 0.180 |
Why?
|
Models, Biological | 1 | 2015 | 9907 | 0.170 |
Why?
|
Palate | 1 | 2018 | 120 | 0.170 |
Why?
|
Nasal Mucosa | 1 | 2021 | 369 | 0.170 |
Why?
|
Cross-Sectional Studies | 6 | 2019 | 23020 | 0.170 |
Why?
|
Nose | 2 | 2019 | 488 | 0.170 |
Why?
|
Positive-Pressure Respiration | 1 | 2021 | 591 | 0.160 |
Why?
|
Lymph Nodes | 4 | 2017 | 3409 | 0.160 |
Why?
|
Laryngoplasty | 1 | 2017 | 52 | 0.160 |
Why?
|
Laryngeal Diseases | 1 | 2020 | 251 | 0.160 |
Why?
|
Extracellular Matrix | 1 | 2005 | 1794 | 0.160 |
Why?
|
Hirudins | 1 | 2018 | 174 | 0.160 |
Why?
|
Clavicle | 1 | 2018 | 182 | 0.160 |
Why?
|
Facial Nerve | 1 | 2019 | 275 | 0.160 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 263 | 0.160 |
Why?
|
Thailand | 1 | 2017 | 277 | 0.160 |
Why?
|
Reoperation | 6 | 2018 | 4159 | 0.160 |
Why?
|
Radiation Injuries | 2 | 2018 | 1228 | 0.150 |
Why?
|
Neoplasms, Unknown Primary | 2 | 2016 | 99 | 0.150 |
Why?
|
North America | 2 | 2017 | 1174 | 0.150 |
Why?
|
Accessory Nerve | 1 | 2015 | 12 | 0.150 |
Why?
|
Disease Management | 2 | 2019 | 2536 | 0.150 |
Why?
|
Equipment Design | 2 | 2017 | 3627 | 0.150 |
Why?
|
Immunohistochemistry | 8 | 2019 | 11790 | 0.150 |
Why?
|
United States | 13 | 2019 | 67165 | 0.140 |
Why?
|
Survival Analysis | 6 | 2016 | 10507 | 0.140 |
Why?
|
Credentialing | 1 | 2016 | 131 | 0.140 |
Why?
|
Speech Intelligibility | 1 | 2015 | 68 | 0.140 |
Why?
|
Swine | 3 | 2015 | 5763 | 0.140 |
Why?
|
Republic of Korea | 1 | 2017 | 568 | 0.140 |
Why?
|
Axilla | 1 | 2017 | 534 | 0.140 |
Why?
|
Hospitals, University | 1 | 2017 | 582 | 0.140 |
Why?
|
Chickens | 1 | 2017 | 875 | 0.140 |
Why?
|
Cicatrix | 1 | 2020 | 689 | 0.140 |
Why?
|
Intubation, Gastrointestinal | 1 | 2016 | 145 | 0.140 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 466 | 0.140 |
Why?
|
Quality of Life | 4 | 2021 | 11594 | 0.140 |
Why?
|
Learning Curve | 2 | 2018 | 202 | 0.140 |
Why?
|
DNA, Neoplasm | 3 | 2015 | 1782 | 0.130 |
Why?
|
Neoplasm Invasiveness | 5 | 2016 | 3693 | 0.130 |
Why?
|
SEER Program | 3 | 2020 | 1549 | 0.130 |
Why?
|
Surgical Wound Dehiscence | 1 | 2015 | 215 | 0.130 |
Why?
|
Video-Assisted Surgery | 1 | 2014 | 48 | 0.130 |
Why?
|
Incidence | 7 | 2019 | 20320 | 0.130 |
Why?
|
Periosteum | 1 | 2015 | 140 | 0.130 |
Why?
|
Surgical Instruments | 1 | 2017 | 409 | 0.130 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2017 | 308 | 0.130 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2015 | 109 | 0.130 |
Why?
|
Neoplasms, Nerve Tissue | 1 | 2013 | 25 | 0.120 |
Why?
|
Positron-Emission Tomography | 3 | 2016 | 6170 | 0.120 |
Why?
|
Models, Anatomic | 2 | 2015 | 684 | 0.120 |
Why?
|
Finite Element Analysis | 1 | 2015 | 409 | 0.120 |
Why?
|
Adenoma, Pleomorphic | 1 | 2014 | 76 | 0.120 |
Why?
|
Time Factors | 7 | 2021 | 41038 | 0.120 |
Why?
|
Carbolines | 1 | 2015 | 249 | 0.120 |
Why?
|
Microvessels | 1 | 2018 | 565 | 0.120 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1995 | 421 | 0.120 |
Why?
|
Adenoma | 1 | 2004 | 2130 | 0.120 |
Why?
|
Esthetics | 1 | 2014 | 304 | 0.120 |
Why?
|
Glycosaminoglycans | 2 | 2006 | 601 | 0.120 |
Why?
|
Adolescent | 9 | 2017 | 84718 | 0.120 |
Why?
|
Hashimoto Disease | 1 | 2013 | 93 | 0.120 |
Why?
|
Salivation | 1 | 2012 | 26 | 0.120 |
Why?
|
Young Adult | 9 | 2021 | 55940 | 0.120 |
Why?
|
Multivariate Analysis | 4 | 2017 | 12447 | 0.120 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2019 | 1988 | 0.110 |
Why?
|
Salivary Gland Neoplasms | 1 | 2016 | 295 | 0.110 |
Why?
|
Skull Base Neoplasms | 1 | 2016 | 278 | 0.110 |
Why?
|
Treatment Failure | 1 | 2018 | 2680 | 0.110 |
Why?
|
Analysis of Variance | 3 | 2011 | 6530 | 0.110 |
Why?
|
Dehydration | 1 | 2013 | 240 | 0.110 |
Why?
|
Rhabdomyosarcoma, Alveolar | 1 | 2011 | 39 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3515 | 0.110 |
Why?
|
Time and Motion Studies | 1 | 2011 | 154 | 0.110 |
Why?
|
Baltimore | 1 | 2011 | 235 | 0.110 |
Why?
|
Follow-Up Studies | 7 | 2014 | 39038 | 0.100 |
Why?
|
Saliva | 1 | 2015 | 793 | 0.100 |
Why?
|
In Situ Hybridization | 4 | 2016 | 1988 | 0.100 |
Why?
|
Surgical Staplers | 1 | 2010 | 35 | 0.100 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2011 | 105 | 0.100 |
Why?
|
Stress, Mechanical | 1 | 2015 | 1714 | 0.100 |
Why?
|
Thyroid Nodule | 1 | 2017 | 734 | 0.100 |
Why?
|
Human papillomavirus 11 | 1 | 2009 | 16 | 0.100 |
Why?
|
Radial Artery | 1 | 2011 | 202 | 0.100 |
Why?
|
Risk Factors | 9 | 2022 | 69553 | 0.100 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2009 | 54 | 0.090 |
Why?
|
Phantoms, Imaging | 2 | 2015 | 2401 | 0.090 |
Why?
|
Postoperative Hemorrhage | 1 | 2013 | 416 | 0.090 |
Why?
|
Forearm | 1 | 2011 | 406 | 0.090 |
Why?
|
Aorta, Thoracic | 1 | 2015 | 1045 | 0.090 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2011 | 144 | 0.090 |
Why?
|
Cohort Studies | 8 | 2022 | 39292 | 0.090 |
Why?
|
Cysts | 1 | 2014 | 630 | 0.090 |
Why?
|
Quality Assurance, Health Care | 1 | 2020 | 2274 | 0.090 |
Why?
|
Intraoperative Period | 1 | 2010 | 538 | 0.090 |
Why?
|
Stroboscopy | 1 | 2009 | 66 | 0.090 |
Why?
|
Proportional Hazards Models | 5 | 2017 | 12292 | 0.090 |
Why?
|
Papilloma | 1 | 2009 | 154 | 0.090 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1480 | 0.090 |
Why?
|
Disability Evaluation | 1 | 2016 | 1829 | 0.090 |
Why?
|
Patient Satisfaction | 1 | 2021 | 3376 | 0.090 |
Why?
|
Practice Guidelines as Topic | 2 | 2016 | 7487 | 0.090 |
Why?
|
Immunity, Cellular | 1 | 2015 | 1693 | 0.090 |
Why?
|
Radiotherapy | 2 | 2021 | 1623 | 0.090 |
Why?
|
Linear Models | 2 | 2020 | 5986 | 0.090 |
Why?
|
Bone Transplantation | 1 | 2013 | 930 | 0.080 |
Why?
|
Carcinoma, Papillary | 1 | 2013 | 798 | 0.080 |
Why?
|
Regression Analysis | 2 | 2017 | 6451 | 0.080 |
Why?
|
Soft Tissue Injuries | 1 | 2009 | 179 | 0.080 |
Why?
|
Voice Quality | 1 | 2009 | 221 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6850 | 0.080 |
Why?
|
Immunoglobulin G | 2 | 1998 | 4422 | 0.080 |
Why?
|
Radiopharmaceuticals | 2 | 2016 | 2708 | 0.080 |
Why?
|
Endopeptidase K | 1 | 2006 | 25 | 0.080 |
Why?
|
Sarcoma | 1 | 2018 | 1854 | 0.080 |
Why?
|
Intensive Care Units | 2 | 2017 | 3418 | 0.080 |
Why?
|
Pain Measurement | 1 | 2017 | 3510 | 0.080 |
Why?
|
Osmotic Pressure | 2 | 1998 | 165 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 5 | 2016 | 20308 | 0.080 |
Why?
|
Postoperative Period | 3 | 2018 | 1843 | 0.080 |
Why?
|
Voice Disorders | 1 | 2009 | 272 | 0.070 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2011 | 450 | 0.070 |
Why?
|
Ultrasonography | 2 | 2017 | 5918 | 0.070 |
Why?
|
Compressive Strength | 1 | 2006 | 162 | 0.070 |
Why?
|
Program Development | 1 | 2012 | 1328 | 0.070 |
Why?
|
Antibodies, Viral | 1 | 2017 | 2930 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2176 | 0.070 |
Why?
|
Survivors | 1 | 2016 | 2149 | 0.070 |
Why?
|
Tissue Engineering | 2 | 2006 | 1852 | 0.070 |
Why?
|
Hydrolysis | 1 | 2006 | 728 | 0.070 |
Why?
|
Predictive Value of Tests | 6 | 2019 | 15252 | 0.070 |
Why?
|
Animals | 8 | 2017 | 170486 | 0.070 |
Why?
|
Graft Rejection | 2 | 2018 | 4408 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2016 | 2315 | 0.070 |
Why?
|
Logistic Models | 3 | 2016 | 13468 | 0.070 |
Why?
|
Tensile Strength | 1 | 2005 | 342 | 0.070 |
Why?
|
Carotid Arteries | 1 | 2009 | 977 | 0.070 |
Why?
|
Cell Membrane Permeability | 1 | 2006 | 640 | 0.070 |
Why?
|
Voice | 1 | 2007 | 245 | 0.070 |
Why?
|
Probability | 1 | 2009 | 2474 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2971 | 0.060 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2005 | 349 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3690 | 0.060 |
Why?
|
Patient Readmission | 2 | 2016 | 2952 | 0.060 |
Why?
|
Biopsy | 2 | 2014 | 6766 | 0.060 |
Why?
|
Anisotropy | 1 | 2006 | 1235 | 0.060 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2005 | 629 | 0.060 |
Why?
|
Radiation Dosage | 1 | 2012 | 2041 | 0.060 |
Why?
|
Melanoma | 1 | 2021 | 5194 | 0.060 |
Why?
|
Antisepsis | 1 | 2022 | 19 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8024 | 0.060 |
Why?
|
Physicians | 1 | 2020 | 4292 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3562 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2017 | 726 | 0.060 |
Why?
|
Comorbidity | 2 | 2014 | 10339 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3708 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2009 | 2502 | 0.050 |
Why?
|
Embolization, Therapeutic | 2 | 2009 | 1419 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2005 | 647 | 0.050 |
Why?
|
DNA Methylation | 1 | 2015 | 4099 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2022 | 21194 | 0.050 |
Why?
|
Oropharynx | 1 | 2021 | 131 | 0.050 |
Why?
|
Neuroglia | 2 | 1996 | 930 | 0.050 |
Why?
|
Enzyme Induction | 2 | 1998 | 515 | 0.050 |
Why?
|
Temperature | 1 | 2006 | 2144 | 0.050 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2005 | 844 | 0.050 |
Why?
|
Health Care Costs | 1 | 2013 | 3152 | 0.050 |
Why?
|
Databases, Factual | 2 | 2014 | 7763 | 0.050 |
Why?
|
Sex Distribution | 2 | 2016 | 2328 | 0.050 |
Why?
|
Sural Nerve | 1 | 2019 | 111 | 0.050 |
Why?
|
Palate, Soft | 1 | 2019 | 101 | 0.050 |
Why?
|
Age Distribution | 2 | 2016 | 2876 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2015 | 4173 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 3006 | 0.040 |
Why?
|
Computer Simulation | 1 | 2012 | 6048 | 0.040 |
Why?
|
Survival Rate | 3 | 2021 | 13202 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 3 | 2015 | 17218 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9556 | 0.040 |
Why?
|
Prolapse | 1 | 2017 | 60 | 0.040 |
Why?
|
Pilot Projects | 2 | 2021 | 7994 | 0.040 |
Why?
|
Child | 5 | 2017 | 73636 | 0.040 |
Why?
|
Nerve Transfer | 1 | 2019 | 116 | 0.040 |
Why?
|
Collagen | 1 | 2006 | 2687 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 1993 | 0.040 |
Why?
|
Software | 1 | 2011 | 4345 | 0.040 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2005 | 2032 | 0.040 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2017 | 133 | 0.040 |
Why?
|
Sex Factors | 3 | 2017 | 10566 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 3 | 1998 | 8593 | 0.040 |
Why?
|
Speech | 1 | 2021 | 485 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 1998 | 2673 | 0.040 |
Why?
|
Mutation | 3 | 2015 | 29262 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2013 | 8968 | 0.040 |
Why?
|
Fixatives | 1 | 2015 | 101 | 0.030 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2015 | 39 | 0.030 |
Why?
|
Mannitol | 1 | 1995 | 189 | 0.030 |
Why?
|
Oncogene Proteins, Viral | 1 | 2017 | 384 | 0.030 |
Why?
|
Heme Oxygenase-1 | 1 | 1998 | 382 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 3885 | 0.030 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2016 | 152 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6765 | 0.030 |
Why?
|
Hospitalization | 1 | 2014 | 9644 | 0.030 |
Why?
|
Age Factors | 3 | 2020 | 18712 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 500 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 707 | 0.030 |
Why?
|
Gastroscopy | 1 | 2016 | 202 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 305 | 0.030 |
Why?
|
Amines | 1 | 2016 | 292 | 0.030 |
Why?
|
Immunoblotting | 1 | 1998 | 1795 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2009 | 4266 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2015 | 258 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2015 | 317 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6796 | 0.030 |
Why?
|
Formaldehyde | 1 | 2015 | 358 | 0.030 |
Why?
|
Drinking | 1 | 2014 | 186 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18375 | 0.030 |
Why?
|
Ear Auricle | 1 | 2012 | 35 | 0.030 |
Why?
|
Radiotherapy, Conformal | 1 | 2016 | 563 | 0.030 |
Why?
|
Esophagectomy | 1 | 2016 | 458 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 1995 | 1853 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2920 | 0.030 |
Why?
|
Radiotherapy, High-Energy | 1 | 2012 | 244 | 0.030 |
Why?
|
Hemostasis, Surgical | 1 | 2012 | 131 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2713 | 0.030 |
Why?
|
Asian Americans | 1 | 2017 | 699 | 0.030 |
Why?
|
Bronchoscopy | 1 | 2017 | 842 | 0.030 |
Why?
|
Needs Assessment | 1 | 2018 | 1147 | 0.030 |
Why?
|
Seroma | 1 | 2011 | 65 | 0.030 |
Why?
|
Rats | 3 | 1998 | 25094 | 0.030 |
Why?
|
Osteoradionecrosis | 1 | 2011 | 53 | 0.030 |
Why?
|
Metagenome | 1 | 2014 | 388 | 0.030 |
Why?
|
Hypocalcemia | 1 | 2011 | 197 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 996 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2016 | 1114 | 0.020 |
Why?
|
Thigh | 1 | 2010 | 232 | 0.020 |
Why?
|
Preoperative Period | 1 | 2011 | 552 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2005 | 20170 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2014 | 1066 | 0.020 |
Why?
|
Analgesics | 1 | 2016 | 1008 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 19423 | 0.020 |
Why?
|
Child, Preschool | 1 | 2011 | 41081 | 0.020 |
Why?
|
Vocal Cord Paralysis | 1 | 2011 | 251 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2015 | 1433 | 0.020 |
Why?
|
Prevalence | 2 | 2016 | 14712 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2320 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2015 | 1807 | 0.020 |
Why?
|
Smoking | 2 | 2014 | 8612 | 0.020 |
Why?
|
Vocal Cords | 1 | 2011 | 498 | 0.020 |
Why?
|
Hematoma | 1 | 2011 | 732 | 0.020 |
Why?
|
Face | 1 | 2012 | 973 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 1894 | 0.020 |
Why?
|
Disease Progression | 2 | 2015 | 13298 | 0.020 |
Why?
|
Radiology | 1 | 2019 | 1931 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 3075 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2709 | 0.020 |
Why?
|
Brain Injuries | 1 | 1996 | 1909 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4941 | 0.020 |
Why?
|
Critical Care | 1 | 2017 | 2473 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2011 | 2146 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2013 | 3245 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2009 | 1219 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 5112 | 0.020 |
Why?
|
Blood Pressure | 2 | 1996 | 8528 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 6991 | 0.010 |
Why?
|
Fees, Medical | 1 | 2002 | 115 | 0.010 |
Why?
|
Gene Expression | 1 | 1995 | 8014 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2013 | 6127 | 0.010 |
Why?
|
Ligation | 1 | 2002 | 481 | 0.010 |
Why?
|
African Americans | 1 | 2017 | 5118 | 0.010 |
Why?
|
Wound Healing | 1 | 2011 | 2800 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4254 | 0.010 |
Why?
|
Contrast Media | 1 | 2012 | 5267 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 13314 | 0.010 |
Why?
|
Genomics | 1 | 2014 | 5300 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1995 | 9584 | 0.010 |
Why?
|
Calcium | 1 | 2011 | 5825 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16306 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10362 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2002 | 1652 | 0.010 |
Why?
|
Neurons | 1 | 1995 | 9385 | 0.010 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1996 | 517 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 13274 | 0.010 |
Why?
|
Oligodendroglia | 1 | 1996 | 525 | 0.010 |
Why?
|
Algorithms | 1 | 2013 | 13647 | 0.010 |
Why?
|
Brain | 1 | 1996 | 24969 | 0.010 |
Why?
|
Cerebellum | 1 | 1996 | 1489 | 0.010 |
Why?
|
Astrocytes | 1 | 1996 | 1229 | 0.010 |
Why?
|
Microglia | 1 | 1996 | 1160 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1996 | 5703 | 0.000 |
Why?
|